About us
Expertise
International
People
Careers
News & publications
Contact us
Home
»
News & publications
»
Latest news
News & publications
Related news & insights - James Went
Penningtons Manches Cooper advises Seedrs on $100 million acquisition by Republic
Posted: 08/09/2022
The corporate team at Penningtons Manches Cooper has advised Seedrs, Europe’s leading online private investment platform, on its completed acquisition by Republic for $100 million. This is a landmark transaction which creates a business working globally to transform the world of private investment......>>
Corporate team advises crop protection discovery company on £35 million funding round
Posted: 20/06/2022
The corporate team at Penningtons Manches Cooper has advised Oxford based moa Technology Ltd on the completion of their £35 million ($44 million) Series B financing round......>>
Penningtons Manches Cooper advises innovative fuel cell company Bramble Energy on £35 million Series B financing round
Posted: 16/02/2022
The corporate team at Penningtons Manches Cooper has advised Bramble Energy on the completion of their £35 million Series B financing round. The financing will allow Bramble Energy to roll out its portable power products globally, as well as continue to develop its liquid cooled fuel cell stack capability......>>
Penningtons Manches Cooper advises fusion energy company First Light Fusion on $45 million Series C financing round
Posted: 15/02/2022
The corporate team at Penningtons Manches Cooper has advised First Light Fusion on the completion of their $45 million Series C financing round. The new funding will be used to accelerate the development of First Light’s technology and to perform further design and engineering work on a First Of A Kind commercial fusion energy power plant based on their technology......>>
Penningtons Manches Cooper advises medtech business Orthox on $12.5 million Series A financing round
Posted: 11/02/2022
The corporate team at Penningtons Manches Cooper has advised Oxford University spin-out Orthox Limited on the completion of a further $4.3 million (£3.2 million) to close its $12.5 million (£9.2 million) Series A financing round. The financing will support further clinical trials of its lead product, FibroFix™, at Southmead Hospital Bristol, UK and in Budapest, Hungary.
Corporate team advises on sale of AI spinout to Meltwater
Posted: 29/11/2021
The corporate team at Penningtons Manches Cooper has advised the selling shareholders of Oxford spin-out DeepReason.ai on its acquisition by leading media intelligence SaaS provider Meltwater BV for $7.3 million in a combination of cash and Meltwater equity including earn-outs. The DeepReason.ai team will join Meltwater......>>
National Security and Investment Act: implications for life sciences businesses
Posted: 13/05/2021
The National Security and Investment Act 2021 represents a major change in UK regulation of takeover and investment transactions, giving the Government power to intervene in a wide range of transactions on national security grounds. The new powers can be applied to any business but a mandatory notification regime applies to 17 sectors...…>>
Penningtons Manches Cooper advise medtech spin-out on Series A funding round
Posted: 11/05/2021
The corporate team at Penningtons Manches Cooper has advised Oxford Endovascular, an Oxford-based medtech company spun-out from Oxford University, on its Series A funding round......>>
Penningtons Manches Cooper acts for Metrion Biosciences Ltd on £2.7 million new equity financing
Posted: 29/04/2021
The corporate team at Penningtons Manches Cooper has advised Metrion Biosciences, one of partner Helen Drayton’s long-standing Cambridge based clients, on securing £2.7 million in new equity financing, including £2.25 million from lead investor Gresham House Ventures. Metrion is a drug discovery company focused......>>
1
2
3
4
Filter news & insights
Filter by keyword:
Filter by expertise:
Select an area of expertise
Banking and finance
Cauda Equina Syndrome claims
Charities
Clinical negligence
Commercial
Company secretarial services
Construction and infrastructure
Corporate
Corporate tax
Cosmetic surgery claims
Court of Protection and deputyships
Cyber security and cyber crime
Cycle and bike accident claims
Data protection and privacy
Digital business
Education
Elderly care claims
Employee share schemes
Employment for Business
Employment for Individuals
Energy regulatory
Equity capital markets
Family law
Fashion and luxury brands
Financial services
Financial services regulation
Fintech
Funding a personal injury claim
Gender pay gap reporting
Holiday accident claims
Hospital fall claims
Housing
Housing governance
Immigration for Business
Inquest representation
Inquest representation
Intellectual property
International trade
IT and telecommunications
Life sciences
Marine, trade and energy
Ophthalmology claims
Pensions
Personal injury
Planning
Private client and tax
Product liability claims
Product liability claims
Real estate
Real estate investors
Real estate litigation
Regulatory compliance
Renewable energy and cleantech
Residential property and conveyancing
Retail
Shipping
Social housing management
Sports
Stillbirth and neonatal death claims
Surgical error claims
Technology
Technology transfer and spin-outs
Vaginal mesh claims
In this section
Latest news
Archive news
Publications
Media enquiries
Contact our press team on:
+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)